Your session is about to expire
← Back to Search
Behavioural Intervention
Robotic Balance Training + Brain Stimulation for Traumatic Brain Injury
N/A
Waitlist Available
Led By Vikram Shenoy Handiru, Ph.D.
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Complaints of impaired balance and poor postural control determined by a BBS score of ≤50
Minimum Cognitive Ability to understand the verbal instructions and comply with the study procedures, as determined by the University of California, San Diego, Brief Assessment of Capacity to Consent Instrument (UBACC)
Must not have
Any other neurological injury or psychiatric conditions (e.g., severe anxiety or schizophrenia, etc.)
History of stroke or penetrating TBI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post 4-week training, 2-month follow-up
Summary
"This trial, called NEUROBALANCE, will test if a combination of robotic balance training and noninvasive brain stimulation can help improve balance in individuals with chronic traumatic brain injury. 45 participants
Who is the study for?
This trial is for individuals aged 18-75 who have had a non-penetrating traumatic brain injury (TBI) at least six months ago and are experiencing balance issues. They must be able to stand with or without support, walk at least ten meters, not change medications soon, and understand instructions.
What is being tested?
The NEUROBALANCE study tests if robotic balance training combined with brain stimulation can improve balance in people with chronic TBI. Participants will be divided into three groups: one receiving active brain stimulation, another sham stimulation, and the last standard care.
What are the potential side effects?
Potential side effects may include discomfort from the brain stimulation device or fatigue from the physical demands of balance training. However, specific side effects related to this intervention are not detailed in the provided information.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have trouble with balance and posture, scoring 50 or less on the BBS.
Select...
I can understand and follow study instructions.
Select...
I can walk at least 10 meters with or without help.
Select...
I am between 18 and 75 years old.
Select...
I can stand up straight for at least 20 seconds, with or without support.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have severe mental health conditions like severe anxiety or schizophrenia.
Select...
I have had a stroke or a serious brain injury.
Select...
I had nerve, muscle, or bone issues in my legs before my brain injury.
Select...
I have a skin condition like psoriasis or eczema on my scalp.
Select...
I don't have metal implants in my head or a history of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post 4-week training, 2-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post 4-week training, 2-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Berg Balance Scale (BBS)
Secondary study objectives
Center of Pressure (COP) Displacement
Dizziness Handicap Inventory (DHI)
EEG Corticocortical Functional Connectivity
+8 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: SOC Control GroupExperimental Treatment1 Intervention
The SOC control group participants will perform conventional physical therapy exercises delivered by a trained PT.
Group II: RBT + Active HD-tDCS GroupExperimental Treatment1 Intervention
Participants will engage in balance and postural control training on a robotic balance platform called Hunova (Movendo, Italy). Before balance training, the current intensity of 2 mA will be delivered to the leg motor area identified using neuronavigated transcranial magnetic stimulation, and the stimulation will be turned ON for 20 minutes.
Group III: RBT + Sham HD-tDCS GroupPlacebo Group1 Intervention
Participants will engage in balance and postural control training on a robotic balance platform called Hunova (Movendo, Italy). Before balance training, the current intensity of 2 mA will be delivered to the leg motor area identified using neuronavigated transcranial magnetic stimulation, and the stimulation will be turned ON transiently for 30 s, to provide a sensation of stimulation.
Find a Location
Who is running the clinical trial?
United States Department of DefenseFED
906 Previous Clinical Trials
333,325 Total Patients Enrolled
Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,034 Total Patients Enrolled
Vikram Shenoy Handiru, Ph.D.Principal InvestigatorKessler Foundation
Share this study with friends
Copy Link
Messenger